abrdn Life Sciences Investors
HQL- Exchange
- NYSE
- SEC CIK
- 0000884121
In the last 90 days, abrdn Life Sciences Investors insiders filed 1 open-market purchase and 0 sales; 84 institutions reported holding it in 13F filings for Q2 2026, worth $156.5M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by abrdn Life Sciences Investors insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 1 filing
- 1 insider, $10.5K in total
- Open-market sells
- 0 filings
- Insiders trading
- 1
- Net value
- +$10.5K
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for abrdn Life Sciences Investors, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Mahai Chris LaVictoire | Director | 527 | Jul 20, 2026 | 1 |
| Pittard Christian | Director | 7,923 | Dec 18, 2025 | 1 |
| Saba Capital Management, L.P. | 10% Owner | 2,837,633Indirect | Sep 23, 2025 | 0 |
| Weinstein Boaz | 10% Owner | 2,968,623Indirect | Sep 4, 2025 | 0 |
| Maher Bill | Director | 1,715Indirect | Aug 27, 2024 | 0 |
| DiMartino Rose | Director | 1,000 | Jul 18, 2024 | 0 |
| Goetz Kathleen | Director | 1,085 | Apr 12, 2024 | 0 |
| Reit Todd | Director | 1,000 | Jan 4, 2024 | 0 |
| Omstead Daniel R | President | 197,518 | Sep 25, 2023 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 25, 2025 (view filing)9:43 AM ET | Aug 21 | 4 days | Saba Capital Management, L.P. and 1 other10% Owner | SSale | −10.7K | $14.07 | −$150.7K | −0.4%3.01M after | |
| Aug 27, 2025 (view filing)5:45 PM ET | Aug 26 | 1 day | Saba Capital Management, L.P. and 1 other10% Owner | SSale | −400 | $13.83 | −$5.53K | 0.0%3.01M after | |
| Sep 2, 2025 (view filing)2:40 PM ET | Aug 29 | 4 days | Saba Capital Management, L.P. and 1 other10% Owner | SSale | −23.7K | $13.89 | −$329.5K | −0.8%2.98M after | |
| Sep 4, 2025 (view filing)10:52 AM ET | Sep 2 | 2 days | Saba Capital Management, L.P. and 1 other10% Owner | SSale | −14.1K | $14.04 | −$197.7K | −0.5%2.97M after | |
| Sep 15, 2025 (view filing) | Sep 11 | 4 days | Saba Capital Management, L.P.10% Owner | SSale | −15.1K | $14.28 | −$215.9K | −0.5%2.95M after | |
| Sep 17, 2025 (view filing) | Sep 15-16 | 2 days | Saba Capital Management, L.P.10% Owner | SSale | −2.73K | $14.03 | −$38.2K | −0.1%2.95M after | 2 lots |
| Sep 19, 2025 (view filing) | Sep 17-18 | 2 days | Saba Capital Management, L.P.10% Owner | SSale | −64.5K | $14.04 | −$906.1K | −2.2%2.89M after | 2 lots |
| Sep 23, 2025 (view filing) | Sep 19-22 | 4 days | Saba Capital Management, L.P.10% Owner | SSale | −48.6K | $14.13 | −$687.1K | −1.7%2.84M after | 2 lots |
| Dec 18, 2025 (view filing) | Dec 16 | 2 days | Pittard ChristianDirector | PPurchase | +7.92K | $16.88 | +$133.7K | New position7.92K after | |
| Jul 20, 2026 (view filing)2:36 PM ET | Jul 16 | 4 days | Mahai Chris LaVictoireDirector | PPurchase | +527 | $19.92 | +$10.5K | New position527 after |